August 03, 2016
Biotica Pharmaceuticals Inc. (St. Petersburg, FL) has elected Abbott and Bayer veteran Dr. P.C. Sundareswaran as its President & CEO.
The company reports that Sundareswaran's "expertise in growing and scaling businesses, developing winning strategies, operations, marketing, sales and innovation for global businesses and broad brand portfolios" will will lead Biotica in discovering, developing, and commercializing cannabinoid-based medicines for neuropathic pain, cancer, Alzheimer's, Parkinson's Disease and esophagitis.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.